Vitargent has developed an award-winning toxicity test method that utilizes medaka and zebrafish embryos. They test the products of their clients along the whole production chain from the raw materials to the packaging materials which makes up for a comprehensive safety test for the products. Their safety test is globally trusted and can enhance the brand value of their clients and give suggestions to them to further improve their product by employing safer choices.
| Company Name | Vitargent (International) Biotechnology Limited. |
| Brand Name | Vitargent |
| Industries | BioTech |
| Year of Establishment | 2010 |
| Founder(s) | Eric Chen |
| No. of Employees | 11-30 |
| Regional Coverage | Hong Kong China |
| Clients | / |
| Stage | Undisclosed (2018), Series A (2015) |
| Investor(s) | WI Harper Group |
| Raising Fund | / |
| Pre-money valuation | / |
| Post-money Valuation | / |
| Fundraising target | / |
| Fundraising History | / |
| Media Explosure | 21-50 |
| Company Email | [email protected] |
[dcb id=5586]